Arora A, Bhaskarane H, Tansir G, Bakhshi S, et al. A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC Ann Oncol 2025 Dec 22:S0923-7534(25)06335-5. doi: 10.1016/j.annonc.2025.
PMID: 41443410